家庭での血圧測定が心筋梗塞予防に有効である可能性 (Home Blood Pressure Tests May Prevent Heart Attacks)

ad

2026-06-11 エディンバラ大学

英国のThe University of Edinburghの研究チームは、自宅での血圧測定とデジタル共有システムを活用することで、心筋梗塞や脳卒中などの心血管疾患リスクを低減できることを明らかにした。研究では、高血圧患者が家庭で血圧を測定し、そのデータをインターネットやSMS経由で医療機関へ送信する「Scale-Up BP」システムを利用した場合、通常診療を受ける患者よりも血圧管理が改善したことが確認された。高血圧は心筋梗塞や脳卒中の最大の治療可能な危険因子であるが、従来は医療機関での定期測定に依存していた。新システムでは、家庭で得られた複数の測定値を医師が継続的に把握できるため、より正確な評価と迅速な治療調整が可能となる。また、対面受診回数も減少し、医療資源の効率化にも寄与した。研究成果は、遠隔医療や地域医療の強化に加え、高血圧管理を通じた心血管疾患予防の有効な手段として期待されている。

<関連情報>

血圧遠隔モニタリングと心血管イベント発生率:記録に基づくマッチング患者分析 Blood pressure telemonitoring and the incidence of cardiovascular events: a records based, matched patient analysis

Janet Hanley,Mary Paterson,Richard Parker,Alice Pearsons,Roz Pollock,Lis Neubeck,Iain Atherton,Brian McKinstry
European Heart Journal – Digital Health  Published:26 May 2026
DOI:https://doi.org/10.1093/ehjdh/ztag069

家庭での血圧測定が心筋梗塞予防に有効である可能性 (Home Blood Pressure Tests May Prevent Heart Attacks)

Abstract

Aims

It is well established from trials that blood pressure (BP) telemonitoring leads to improved BP control. However, there is little data available on the impact of BP telemonitoring on the incidence of cardiovascular events when it is used as the routine mode of long-term BP monitoring. The objective of this study was to assess the impact of BP telemonitoring on cardiovascular outcomes.

Methods and results

Records were analysed for 454 180 adults with hypertension who had a prescription for a first-line anti-hypertensive drug at any time from 1 March 2019 to 28 February 2021. Follow-up was until 1st March 2022. Women pregnant during that time were excluded. The primary outcome was emergency hospital admission or mortality for Acute Coronary Syndrome (ACS), Stroke, or uncontrolled Heart Failure (HF) within 12 months. Outcomes were compared between people who had used BP telemonitoring for at least 1 year and a group who had never used it, matched for age, sex, ethnicity, social deprivation, number of anti-hypertensive drugs, diabetes, and having a BP assessment in the same year. Ninety percent of the cohort had been diagnosed with hypertension before March 2019. The onset of the COVID-19 pandemic in March 2020 was associated with a rapid increase in the uptake of BP telemonitoring but a reduction in the number of new diagnoses of hypertension. Those who used telemonitoring were significantly younger, less likely to have diabetes, and took less antihypertensive medication. For those who used telemonitoring for over 1 year, a mean reduction in systolic BP was seen by 3 months which was maintained for at least the remainder of the year.

Conclusion

In the matched cohort analysis, people who used telemonitoring were less likely to be admitted to hospital with or die from ACS, stroke, or uncontrolled HF telemonitoring [adjusted OR 0.665 (0.501 to 0.884), P = 0.0049] than those who were not using telemonitoring.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました